Riskpilot← Back to searchSign inGet full accessArtivity Vol.1 AB
ABActiveOrg 5592527062Björketvägen 2General medical practice activities · NACE 8621Est. 20201 employees
Revenue 2025
SEK 3,3M
-32% vs 2024
EBITDA margin
83.1%
-37% vs 2024
Equity ratio
66.1%
Financial strength
Net profit 2025
SEK 1,6M
-38% vs 2024
| Revenue | SEK 3,3M | -32% |
| EBITDA | SEK 2,7M | -37% |
| Net profit | SEK 1,6M | -38% |
| Total assets | SEK 6,5M | +16% |
| Equity | SEK 4,3M | +47% |
| Employees | 1 | — |
Legal name
Artivity Vol.1 AB
Org number
5592527062
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 april 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Artivity AB ska driva konsultverksamhet inom hälso- och sjukvård, läkaruthyrning samt uthyrning av annan personal inom sjukvård. Aktiebolaget handlar även med värdepapper, äger och förvaltar aktier och andelar i dotter- och intressebolag samt därmed förenlig verksamhet. Aktiebolaget investerar även i samlarkort samt äger fastigheter. Bolaget ska även bedriva estetiska skönhetsbehandlingar.
Address
Björketvägen 2
Email
coufalpavel5@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 529 | 4 804 | 3 271 |
| Staff expenses | — | — | −29 | −346 | −429 |
| EBITDA | — | −1 | 1 416 | 4 346 | 2 719 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 0 | −1 | 1 416 | 4 346 | 2 719 |
| Net financials | — | — | −446 | −930 | −18 |
| Profit before tax | 0 | −1 | 720 | 3 416 | 2 101 |
| Tax | −0 | — | −160 | −901 | −530 |
| Net profit | 0 | −1 | 560 | 2 515 | 1 571 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 50 | 22 | 1 259 | 5 576 | 6 467 |
| Equity | 50 | 22 | 581 | 2 901 | 4 272 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | 427 | 2 425 | 1 344 |
| Total debt | — | — | 427 | 2 425 | 1 344 |
EBITDA margin
83.1%
This company
15.8%
Market median
+426% vs market
20212025
Equity ratio
66.1%
This company
38.2%
Market median
+73% vs market
20212025
Return on equity
36.8%
This company
18.4%
Market median
+100% vs market
20212025
Net profit margin
48.0%
This company
8.1%
Market median
+493% vs market
20212025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20212025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Artivity Vol.1 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pavel Coufal | Board of Directors | 0 companies |
| Radmila Coufalova | Deputy Board Member | 0 companies |